Castella M,Pujol R,Callén E,Ramírez MJ,Casado JA,Talavera M .2011 .Chromosome fragility in patients with Fanconi anaemia: diagnostic implications and clinical impact. J Med Genet, 48 : 242-50.
Rodríguez A,D'Andrea A. .2017 .Fanconi anemia pathway. Curr Biol, 27 : 986-8.
Niraj J,Färkkilä A,D'Andrea AD A .2019 .The Fnconi anemia pathway in Cancer. Annu Rev Cancer Biol, 3 : 457-78.
Aziz MA,Chowdhury MU,Khan R,Shah MS,Islam S .2017 .. Fanconi anaemia a rare case report. Bangladesh Med Res Counc Bull, 42 : 147-9.
Kee Y,D'Andrea AD Y .2012 .Molecular pathogenesis and clinical management of Fanconi anemia. J Clin Invest, 122 : 3799-806.
De Winter JP,Joenje H. .2009 .The genetic and molecular basis of Fanconi anemia. Mutat Res, 668 : 11-9.
Ceccaldi R,Sarangi P,D'Andrea AD P .2016 .The Fanconi anaemia pathway: new players and new functions. Nat Rev Mol Cell Biol, 17 : 337-49.
Soulier J,Leblanc T,Larghero J,Dastot H,Shimamura A,Guardiola P .2005 .Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway. Blood, 105 : 1329-36.
Townsley DM,Dumitriu B,Young NS .2014 .Bone marrow failure and the telomeropathies. Blood, 124 : 2775-83.
Rose SR,Kim MO,Korbee L,Wilson KA,Ris MD,Eyal O .2014 .Oxandrolone for the treatment of bone marrow failure in Fanconi anemia. Pediatr Blood Cancer, 61 : 11-9.
Yoon BG,Kim HN,Han UJ,Jang HI,Han DK,Baek HJ .2014 .Long-term follow-up of Fanconi anemia: clinical manifestation and treatment outcome. Korean J Pediatr, 57 : 125-34.
Shafqat S,Tariq E,Parnes AD,Dasouki MJ,Ahmed SO,Hashmi SK .2021 .Role of gene therapy in Fanconi anemia: a systematic and literature review with future directions. Hematol Oncol Stem Cell Ther, 3876 : 00026-1.
Siddiqui F,Ansari S,Agha A,Nusrat N,Munzir S,Shan S .2020 .Chromosomal breakage in Fanconi anemia and consanguineous marriages: a social dilemma for developing countries. Cureus, 12 : e10440.